What are the implications of an Anti-Müllerian Hormone (AMH) level of 0.4 on fertility?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Implications of AMH Level of 0.4 on Fertility

An AMH level of 0.4 ng/ml indicates significantly diminished ovarian reserve, which is associated with reduced fertility potential and possibly increased risk of miscarriage. 1

Understanding AMH and Ovarian Reserve

  • AMH is secreted by granulosa cells of growing follicles and serves as a reliable marker of ovarian reserve, with strong correlation to antral follicle count 2
  • AMH levels naturally decline with age and are proportional to the number of small antral follicles remaining in the ovaries 3
  • Low AMH levels (below 0.7 ng/ml) are indicative of incipient ovarian insufficiency 1
  • AMH is considered the best endocrine marker to assess age-related decline in ovarian reserve in healthy women 1

Clinical Significance of AMH 0.4

Fertility Implications

  • AMH of 0.4 ng/ml falls below the threshold of 0.7 ng/ml, which has been associated with diminished ovarian reserve 4
  • This level suggests a reduced ovarian follicle pool, which may impact natural conception chances 2
  • Meta-analysis data indicates women with low AMH concentrations have an increased risk of miscarriage compared to those with medium or high AMH levels 1
  • For IVF/IVM treatments, an AMH level below 1.56 ng/ml is associated with retrieving fewer than 5 oocytes, suggesting potentially reduced response to ovarian stimulation 5

Risk Assessment

  • Low AMH (below 0.7 ng/ml) may be associated with slightly higher miscarriage risk, though evidence is still being developed 1
  • Women with diminished ovarian reserve (AMH <1 ng/ml) may have higher rates of aneuploid embryos, potentially contributing to pregnancy loss 1
  • Despite low AMH, some studies show that women can still conceive naturally, though time to conception may be longer 4

Age Considerations

  • The interpretation of AMH of 0.4 should be age-dependent 1:
    • In women under 25 years: May require cautious interpretation as AMH fluctuations can occur 1
    • In women 25 years and older: More reliably indicates diminished ovarian reserve 1
  • AMH is inversely correlated with age in women ≥25 years, making it a clinically useful marker of ovarian reserve in this age group 1

Management Considerations

  • For women with AMH of 0.4 who desire pregnancy, closer monitoring and potentially earlier referral to reproductive specialists may be warranted 1
  • Laboratory evaluation of FSH and estradiol is recommended for women with suspected diminished ovarian reserve 1
  • Women with irregular menstrual cycles and low AMH should be monitored for symptoms of premature ovarian insufficiency (POI) 1
  • Fertility preservation options should be discussed promptly if future fertility is desired 1

Important Caveats

  • AMH alone cannot predict oocyte or embryo quality, which limits its value as a standalone fertility predictor 2
  • Some women with low AMH levels can still conceive naturally, so AMH should not be used in isolation to counsel about fertility potential 4
  • Individual AMH levels tend to remain relatively stable for a given woman throughout childhood and adolescence, with significant changes primarily occurring during adult reproductive years 6
  • Different AMH assays may yield varying results, so values should be interpreted in the context of the specific laboratory reference ranges 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

AMH as the primary marker for fertility.

European journal of endocrinology, 2019

Research

Anti-Mullerian hormone (AMH): what do we still need to know?

Human reproduction (Oxford, England), 2009

Research

Anti-Müllerian hormone as a predictor of reproductive potential.

Current opinion in endocrinology, diabetes, and obesity, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.